Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
6.71
-0.08 (-1.18%)
May 14, 2025, 4:00 PM - Market closed
Global Medical REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Rental Revenue | 137.94 | 138.41 | 140.93 | 137.17 | 115.8 | 93.52 | Upgrade
|
| Other Revenue | 0.28 | 0.35 | 0.12 | 0.12 | 0.13 | 0.21 | Upgrade
|
| Total Revenue | 138.22 | 138.76 | 141.05 | 137.28 | 115.94 | 93.73 | Upgrade
|
| Revenue Growth (YoY | -1.23% | -1.62% | 2.74% | 18.41% | 23.69% | 32.53% | Upgrade
|
| Property Expenses | 0.36 | 0.16 | 0.04 | 0.35 | 0.15 | 6.3 | Upgrade
|
| Selling, General & Administrative | 53.87 | 54.92 | 50.01 | 46.68 | 35.86 | 25.63 | Upgrade
|
| Depreciation & Amortization | 40.62 | 40.43 | 41.27 | 40.01 | 33.83 | 26.75 | Upgrade
|
| Total Operating Expenses | 104.9 | 105.89 | 103.11 | 98.81 | 78.97 | 65.46 | Upgrade
|
| Operating Income | 33.32 | 32.87 | 37.94 | 38.47 | 36.97 | 28.28 | Upgrade
|
| Interest Expense | -28.97 | -28.69 | -30.89 | -25.23 | -19.7 | -18.68 | Upgrade
|
| EBT Excluding Unusual Items | 4.35 | 4.18 | 7.04 | 13.24 | 17.27 | 9.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.56 | 4.21 | 15.56 | 6.75 | 1.07 | - | Upgrade
|
| Asset Writedown | -1.7 | -1.7 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.1 | - | -0.87 | - | - | -12.09 | Upgrade
|
| Pretax Income | 8.12 | 6.69 | 21.73 | 20 | 18.34 | -2.5 | Upgrade
|
| Earnings From Continuing Operations | 8.12 | 6.69 | 21.73 | 20 | 18.34 | -2.5 | Upgrade
|
| Minority Interest in Earnings | -0.17 | -0.06 | -1.12 | -0.85 | -0.72 | 0.57 | Upgrade
|
| Net Income | 7.94 | 6.63 | 20.61 | 19.14 | 17.62 | -1.93 | Upgrade
|
| Preferred Dividends & Other Adjustments | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 | Upgrade
|
| Net Income to Common | 2.12 | 0.81 | 14.79 | 13.32 | 11.8 | -7.75 | Upgrade
|
| Net Income Growth | -61.69% | -67.82% | 7.68% | 8.63% | - | - | Upgrade
|
| Basic Shares Outstanding | 66 | 66 | 66 | 65 | 61 | 46 | Upgrade
|
| Diluted Shares Outstanding | 66 | 66 | 66 | 65 | 61 | 46 | Upgrade
|
| Shares Change (YoY) | 1.07% | 0.59% | 0.13% | 7.95% | 31.10% | 36.59% | Upgrade
|
| EPS (Basic) | 0.03 | 0.01 | 0.23 | 0.20 | 0.19 | -0.17 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.01 | 0.23 | 0.20 | 0.19 | -0.17 | Upgrade
|
| EPS Growth | -85.79% | -94.55% | 10.89% | 4.57% | - | - | Upgrade
|
| Dividend Per Share | 0.840 | 0.840 | 0.840 | 0.840 | 0.820 | 0.800 | Upgrade
|
| Dividend Growth | - | - | - | 2.44% | 2.50% | - | Upgrade
|
| Operating Margin | 24.10% | 23.69% | 26.90% | 28.02% | 31.89% | 30.17% | Upgrade
|
| Profit Margin | 1.54% | 0.58% | 10.49% | 9.70% | 10.18% | -8.27% | Upgrade
|
| EBITDA | 84.79 | 84.41 | 91.87 | 91.19 | 80.36 | 62.27 | Upgrade
|
| EBITDA Margin | 61.35% | 60.83% | 65.13% | 66.43% | 69.31% | 66.43% | Upgrade
|
| D&A For Ebitda | 51.48 | 51.54 | 53.93 | 52.72 | 43.39 | 33.99 | Upgrade
|
| EBIT | 33.32 | 32.87 | 37.94 | 38.47 | 36.97 | 28.28 | Upgrade
|
| EBIT Margin | 24.10% | 23.69% | 26.90% | 28.02% | 31.89% | 30.17% | Upgrade
|
| Funds From Operations (FFO) | 53.5 | 53.61 | 58.36 | 64.03 | 58.22 | 27.98 | Upgrade
|
| Adjusted Funds From Operations (AFFO) | - | 63.36 | 64.31 | 68.04 | 61.36 | 43.94 | Upgrade
|
| FFO Payout Ratio | 112.50% | 111.68% | 101.14% | 91.24% | 90.18% | 142.75% | Upgrade
|
| Revenue as Reported | 138.28 | 138.78 | 141.05 | 137.28 | 115.94 | 93.73 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.